Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Rosiglitazone potassium
Cat. No.:
OB0425LY-247
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Rosiglitazone potassium is a highly active selective PPARγ agonist.
Synonyms:
Rosiglitazone (potassium salt); 316371-84-3; Potassium 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione; 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, potassium salt
CAS No.:
316371-84-3
Compound CID:
11463585
Formula:
C18H18KN3O3S
Formula Weight:
395.52
Specification
Target:
PPAR; TRP channel; Autophagy; Apoptosis; Ferroptosis
Pathway:
Cell cycle/DNA damage; Metabolic enzyme/Protease; Vitamin D related/Nuclear receptor; Membrane transporter/Ion channel; Neuronal signaling; Autophagy; Apoptosis
Storage:
Storage at -20°C.
Applications:
Rosiglitazone potassium helps reduce postprandial and fasting blood glucose levels and improves the overall metabolic profile in diabetic and obese models.
